Beike Biotechnology is the world's largest stem cell provider, dedicated to the research, development, and clinical application of adult stem cells. Stem cell therapy research is our primary focus, but we have also developed a range of immunotherapy treatments to address various conditions. Our mission is to deliver high-quality treatments to patients worldwide, while fostering collaboration in the field of regenerative medicine.

We work closely with governments and clinicians globally to provide effective stem cell treatments. Founded in 2005, Beike Biotechnology is headquartered in Shenzhen, China. With investments from prestigious institutions such as Peking University and Hong Kong University of Science and Technology, we have assembled a team of over 700 employees, led by esteemed scientists in the stem cell field.

Our cutting-edge research and development initiatives enable us to pioneer groundbreaking approaches to currently incurable diseases and chronic illnesses. At Beike Biotechnology, we are committed to advancing the possibilities of regenerative medicine and improving the lives of patients worldwide